Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV) | Zendy

April C. Pettit | Zendy; Jason E. Stout | Zendy; Robert Belknap | Zendy; Constance A. Benson | Zendy; Marie Nancy Séraphin | Zendy; Michael Lauzardo | Zendy; David Horné | Zendy; Richard S. Garfein | Zendy; Fernanda Maruri | Zendy; Christine Ho | Zendy; Jennifer Flood | Zendy; Lisa Pascopella | Zendy; Julie Higashi | Zendy; Marisa Moore | Zendy; Randall Reves | Zendy; Amina Ahmed | Zendy; Timothy R. Sterling | Zendy; Henry M. Blumberg | Zendy; Richard Brostrom | Zendy; Renuka Khurana | Zendy; Wendy Cronin | Zendy; Susan E. Dorman | Zendy; Masahiro Narita | Zendy; Thaddeus L. Miller | Zendy

Open Access

Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV)

Author(s) -

April C. Pettit,

Jason E. Stout,

Robert Belknap,

Constance A. Benson,

Marie Nancy Séraphin,

Michael Lauzardo,

David Horné,

Richard S. Garfein,

Fernanda Maruri,

Christine Ho,

Jennifer Flood,

Lisa Pascopella,

Julie Higashi,

Marisa Moore,

Randall Reves,

Amina Ahmed,

Timothy R. Sterling,

Henry M. Blumberg,

Richard Brostrom,

Renuka Khurana,

Wendy Cronin,

Susan E. Dorman,

Masahiro Narita,

Thaddeus L. Miller

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa1135

Subject(s) - latent tuberculosis , medicine , tuberculin , tuberculosis , cohort , human immunodeficiency virus (hiv) , interferon gamma release assay , latent class model , quantiferon , prospective cohort study , mycobacterium tuberculosis , immunology , pathology , statistics , mathematics

Increased risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB) disease among people living with human immunodeficiency virus (HIV; PLWH) prioritizes them for LTBI testing and treatment. Studies comparing the performance of interferon gamma release assays (IGRAs) and the tuberculin skin test (TST) among PLWH are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research